Alterity Therapeutics Launches ATH434 Phase 2 Clinical Trial for the Treatment of Patients with Multiple System Atrophy in Europe August 25, 2022May 23, 2023
European Commission Approves PBT2 Orphan Designation for Huntington’s Disease June 1, 2015August 16, 2022